AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Machine learning in drug discovery, along with artificial intelligence, is transforming the pharmaceutical industry by accelerating the development of new treatments. Historically, the process of ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...

In a recent medium.com blog post, Daphne Koller — an artificial intelligence researcher at the Department of Computer Science at Stanford University and, until just a few months ago, chief computing ...

insitro has acquired Israeli AI therapeutics company CombinAbleAI and launched its TherML platform, creating an end-to-end, ...

AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...

(L) First and co-corresponding author Charlie Wright, PhD, St. and (R) co-corresponding author Paul Geeleher, PhD, both of the St. Jude Department of Computational Biology. (MEMPHIS, Tenn. – December ...

Revvity, Inc. RVTY recently announced a collaboration with Eli Lilly and Company to make Eli Lilly’s TuneLab predictive ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. In an era where artificial intelligence (AI) is transforming ...

The rise of machine learning and accurate, physics-based modeling have facilitated breakthroughs in preclinical drug discovery, accelerating discovery of compounds with improved chemical properties at ...